Literature DB >> 8591081

Stratification of palpable and nonpalpable breast cancer by method of detection and age.

P W Perdue1, C Galbo, B C Ghosh.   

Abstract

BACKGROUND: Methods used to diagnose breast cancer in women under the age of 50 years are somewhat controversial. To determine the relationship between type and stage of breast cancer, clinical presentation, and age, we reviewed breast cancer diagnosed at our institution during a recent 3-year period.
METHODS: Records from 589 consecutive excisional biopsies and 372 needle placement biopsies performed over a 3-year period were reviewed. Carcinomas were staged according to the TNM system and results compared using chi 2.
RESULTS: Breast carcinoma was diagnosed in 118 women during the study period, 33% in patients under 50 years of age. Breast cancer diagnosed by mammography in all age groups was more likely to be noninvasive than that diagnosed by physical examination (p < 0.05). The few invasive cancers diagnosed by mammography in women under age 50 were lower in stage than those diagnosed by physical examination, although not by a statistically significant amount (p = 0.125). Breast cancer diagnosed by mammography in women 50 years and older was significantly lower in stage than that diagnosed by physical examination (p < 0.05).
CONCLUSIONS: Invasive carcinoma detected as a nonpalpable lesion by mammography was earlier in stage than invasive carcinoma detected by physical examination, including in women under 50 years of age, although the number of invasive cancers detected in younger women was quite small. The role of mammography in this younger age group remains to be defined.

Entities:  

Mesh:

Year:  1995        PMID: 8591081     DOI: 10.1007/bf02307084

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  Edinburgh trial of screening for breast cancer: mortality at seven years.

Authors:  M M Roberts; F E Alexander; T J Anderson; U Chetty; P T Donnan; P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

2.  Deficiencies in the analysis of breast cancer screening data.

Authors:  E A Sickles; D B Kopans
Journal:  J Natl Cancer Inst       Date:  1993-10-20       Impact factor: 13.506

3.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

Review 4.  Screening for breast cancer.

Authors:  D M Eddy
Journal:  Ann Intern Med       Date:  1989-09-01       Impact factor: 25.391

5.  The effectiveness of breast cancer screening by mammography in younger women.

Authors:  J M Elwood; B Cox; A K Richardson
Journal:  Online J Curr Clin Trials       Date:  1993-02-25

6.  Insights into breast cancer screening of younger women. Evidence from the 14-year follow-up of the Breast Cancer Detection Demonstration Project.

Authors:  C R Smart; W H Hartmann; O H Beahrs; L Garfinkel
Journal:  Cancer       Date:  1993-08-15       Impact factor: 6.860

7.  Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial.

Authors:  K C Chu; C R Smart; R E Tarone
Journal:  J Natl Cancer Inst       Date:  1988-09-21       Impact factor: 13.506

8.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

9.  The value of mammography screening in women under age 50 years.

Authors:  D M Eddy; V Hasselblad; W McGivney; W Hendee
Journal:  JAMA       Date:  1988-03-11       Impact factor: 56.272

10.  Report of the International Workshop on Screening for Breast Cancer.

Authors:  S W Fletcher; W Black; R Harris; B K Rimer; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1993-10-20       Impact factor: 13.506

View more
  1 in total

Review 1.  The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.

Authors:  Lina Romero; Iraj Khalkhali; Hernan I Vargas
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.